BA.3.2, known as the “Cicada” variant, is a new subvariant of the Omicron family of SARS-CoV-2 that is spreading in the United States and 23 other countries worldwide. This subvariant was identified in South Africa during late 2024 and has 70-75 spike protein mutations.
Take Control of Your Health Today
Quickly check your symptoms and understand your prescriptions with our smart, easy-to-use AI tools.
What Is the COVID-19 Cicada Variant (BA.3.2)?
The Cicada is a sublineage of the Omicron variant of SARS-CoV-2. The name “Cicada” derives from the idea that the variant might have evolved silently before its reemergence, similar to a cicada, which develops while dormant and then emerges. The Cicada began infecting people in South Africa towards the end of 2024. Although other variants initially overpowered it, it reappeared after about a year and began causing infections.
The scientists believe that the Cicada possesses between 70 and 75 new mutations in the spike protein segment, which the human body recognizes and reacts against. This number is higher than that of the more prominent variants that emerged in 2023.
How Far Has the Cicada Variant Spread?
As of February 11, the BA.3.2 variant has been reported in at least 25 states in the United States, the CDC announced. BA.3.2 has been identified in nasal samples of travelers, airplane wastewater, patient samples, and wastewater collected from various states.
As of February 11, 2026, BA.3.2 is present in at least 23 countries. Cases have mainly been reported from Denmark, Germany, and the Netherlands. So far, no outbreak has been reported in India due to BA.3.2. Expert advice remains cautious rather than fearful.
What Are the Symptoms of the Cicada Variant?
According to health experts, BA.3.2 “Cicada” coronavirus does not present any additional symptoms compared to the other Omicron strains of COVID-19. However, loss of taste and smell has become rare, but it can still happen.
The typical symptoms of the BA.3.2 strain include:
- Sore throat, which is considered more painful than before
- Dry cough
- Fever or chills
- Fatigue
- Headaches
- Nasal congestion or runny nose
- Body pains
- Difficult breathing for some patients
- Nausea for some patients
Symptoms may vary from patient to patient, but they will disappear on their own. The symptoms are similar to those of a common cold, flu, and RSV. It is important to undergo testing to be properly diagnosed and treated.
Is the Cicada Variant More Dangerous Than Previous COVID Variants?
There is no data to support any association between BA.3.2 and increased severity of illness or hospitalization in those nations where the variant predominates. “It certainly looks scary on paper, but it really hasn’t had much impact as far as disease goes in most places,” says virologist Andrew Pekosz of Johns Hopkins.
While BA.3.2 has been detected in increasing numbers, the virus is circulating at low levels in most countries. In addition, the variant does not currently predominate over other variants. According to the WHO, “BA.3.2 has not demonstrated a sustained growth advantage over any other co-circulating variant.”
Does the COVID Vaccine Work Against the Cicada Variant?
As Cicada belongs to the Omicron family of COVID strains, new vaccines tailored to dominant Omicron strains like JN.1 are effective against BA.3.2. However, they may not offer the same level of protection due to mutations.
According to the WHO, existing COVID-19 vaccines “continue to provide protection from severe disease.” Vaccines are generally updated in the summer and offer protection against various strains.
Are Antiviral Drugs Effective Against the Cicada Variant?
Several experts believe that the new variant remains susceptible to the COVID antivirals we have developed, so at least they will work. Antiviral treatments such as Paxlovid continue to be effective, especially for those who are at high risk of developing complications. Often, doctors prescribe Evimectin-A, Artesunate 200 mg tablets, Artesunate 400 mg tablets, Iverheal 3 mg (Ivermectin), and Mebendazole 100 mg tablets.
If you are infected with the BA.3.2 variant and fall into any of the categories of high-risk patients mentioned, immediately contact your doctor about possible antiviral treatment.
How to Protect Yourself from the Cicada Variant
BA.3.2 virus transmission occurs similarly to that of other COVID-19 variants. You can protect yourself from BA.3.2 by staying up to date on vaccinations, masking indoors, getting tested when symptomatic, and isolating when unwell.
Further guidelines according to health professionals include:
- Washing hands frequently using soap or hand sanitizers containing at least 60% alcohol
- Avoiding physical contact with individuals displaying signs of cold, coughs, or fever
- Ensuring proper ventilation of the spaces you occupy
- Having a balanced meal and drinking water to boost your immunity
- Cleaning commonly touched surfaces
When to See a Doctor?
Those with Cicada variant symptoms generally make a full recovery at home while resting.Â
Contact your doctor if you have:
- A fever of greater than 39 degrees Celsius (103 degrees Fahrenheit) for several days
- Deteriorating symptoms when they should be improving
- Difficulty breathing or shortness of breath
- Chest pains or pressure
- Are older, pregnant, immunocompromised, or have underlying health conditions
How Medipedia Can Help?
If you are experiencing COVID-related symptoms or are unsure whether you need a test, a medical consultation, or a prescription, Medipedia offers an accessible symptom checker to help you monitor your symptoms. Get information about your symptoms, then visit a doctor for further evaluation. At Medipedia, you can access our health and medicine directory, where you will find precise information about COVID-19 medications and learn how to use them for treatment. Medipedia’s approach is to develop an approachable, high-quality healthcare guide. Whether you are dealing with mild or severe symptoms, managing everything becomes easier with Medipedia’s precise guidance and a doctor’s medical assistance.